AstraZeneca and Ironwood announce $150 million China pact
October 25, 2012Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood
AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …
Perception of pharma online ‘negative’
October 25, 2012Medical Communications, Sales and Marketing Digital Health Coalition, Endo, WEGO Health
Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …
Management Forum NSF-DBA Medical Devices Certification Programme
October 24, 2012Research and Development
Management Forum has teamed up with NSF-DBA, experts in medical device professional training, to bring certification programmes aimed at demonstrating …
European green light for Novo’s Tresiba
October 24, 2012Sales and Marketing EMA, Novo Nordisk, Tresiba
The European Medicines Agency has given the go-ahead for Novo Nordisk’s Tresiba, a new basal analogue insulin to treat diabetes …
Streamlining Key Services your Drug Delivery Device Partner Provides
October 24, 2012Manufacturing and Production auto injector, autoinjector, final assembly, pen injector, shl group, shl pharma
Extensive project management expertise and logistical control know-how are obviously required when working on a combination product from the concept …
Merck Serono’s Christoph Schnorr joins Quintiles
October 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christoph Schnorr, Quintiles
Dr Christoph Schnorr has joined Quintiles as head of its European Research and Development consulting practice. Schnorr joins quintiles from Merck …
UK medicine costs ‘under control’
October 24, 2012Sales and Marketing ABPI, PCT, R&D, UK medicine
The ABPI has seized on two reports – one its own and one independent – published this week to assert …
Turkey ‘can be pharma R&D, production hub by 2023’, says PwC
October 23, 2012Manufacturing and Production, Research and Development, Sales and Marketing R&D, Turkey, pwC
Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …
FDA committee recommends Kynamro
October 23, 2012Research and Development, Sales and Marketing FDA, Genzyme, Kynamro, Sanofi
Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …
Dr Reddy’s offers €27m for Dutch formulation firm OctoPlus
October 23, 2012Manufacturing and Production Dr Reddy's, OctoPlus, outsourcing
India’s Dr Reddy’s Laboratories has signed an agreement to buy Netherlands-based formulation and drug delivery specialist OctoPlus in a €27m …
WuXi cuts ribbon on biologics plant
October 23, 2012Manufacturing and Production CGMP, WuXi AppTec
China’s WuXi AppTec has officially opened a new biologics manufacturing facility that forms the centrepiece of the company’s recently-signed alliance …
Pfizer buys NextWave Pharmaceuticals
October 23, 2012Sales and Marketing ADHD, Pfizer, Qullivant, nextwave
Pfizer is to acquire NextWave Pharmaceuticals by the end of the year in a deal that could be worth $680 …
Amgen’s Roger Perlmutter joins Heptares
October 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Heptares, Roger Perlmutter
GPCR drug discovery firm Heptares Therapeutics has elected Dr Roger Perlmutter, the former executive VP, Research and Development, at Amgen …
Coping with transformational change – the key to winning
October 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moorhouse
Imagine you are investing £3.4 billion in changing your business, half of it in business-critical projects such as drug supply …
Catalent licenses taste-masking technology
October 22, 2012Manufacturing and Production Catalent, taste
Catalent Pharma Solutions has licensed a new taste-masking technology that can make “even the most challenging, unpleasant and bitter tasting …
Abbott pulls kidney disease trial
October 22, 2012Research and Development, Sales and Marketing Abbott, Reata, kidney
Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …
AP Pharma appoints Robert Rosen as senior VP and chief commercial officer
October 22, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AP Pharma, Robert Rosen
Specialty pharma firm AP Pharma has announced the appointment of Robert Rosen as senior vice president and chief commercial officer. …
Humira continues to drive Abbott
October 22, 2012Sales and Marketing AbVie, Abbott, Humira, RA
Abbott Laboratories’ rheumatoid arthritis drug Humira has once again shown its value to the company with a strong performance in …
NHS prescribing costs fall
October 22, 2012Sales and Marketing NHS, VBP, prescribing
The Department of Health’s annual report and accounts for 2011-2012 highlights the increasing pressure on the pharma industry to deliver …
OPEN Health acquires market access specialists pH Associates
October 19, 2012Medical Communications Harvey Walsh, Open Health, pH Associates
OPEN Health Communications is to acquire pH Associates, a consultancy specialising in ‘Real World Data’ and market access issues.The health …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
